Manhattan West Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-660
Closed -$220K 152
2024
Q1
$220K Sell
660
-188
-22% -$57.5K 0.05% 141
2023
Q4
$230K Sell
848
-36
-4% -$8.9K 0.06% 126
2023
Q3
$213K Sell
884
-55
-6% -$15.1K 0.07% 128
2023
Q2
$285K Sell
939
-9
-0.9% -$2.5K 0.11% 108
2023
Q1
$250K Buy
948
+25
+3% +$6.35K 0.11% 115
2022
Q4
$221K Buy
+923
New +$207K 0.11% 105
2022
Q2
Sell
-2,015
Closed -$505K 110
2022
Q1
$505K Sell
2,015
-4,111
-67% -$1.03M 0.27% 74
2021
Q4
$1.57M Buy
+6,126
New +$1.5M 0.94% 21

Other funds holding HCA

Manhattan West Asset Management's HCA Position: Q2 2024 in Review

Manhattan West Asset Management sold out of HCA Healthcare (HCA) in Q2 2024, closing a stake of 660 shares — an estimated $220K sold.

Manhattan West Asset Management first reported a position in HCA in Q4 2021 and held it in 8 quarters. The position peaked at $1.57M in Q4 2021. 1,155 funds tracked by Wall St. Rank hold HCA as of Q2 2024.

  • Manhattan West Asset Management reported no remaining HCA Healthcare position as of Q2 2024 after selling out during the quarter.
  • Manhattan West Asset Management sold 660 HCA Healthcare shares in Q2 2024, an estimated $220K.
  • Manhattan West Asset Management first reported a position in HCA Healthcare in Q4 2021 and held it in 8 quarters.
  • Manhattan West Asset Management's HCA Healthcare position peaked at $1.57M in Q4 2021.
  • 1,155 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2024.

Based on Manhattan West Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.